AbbVie
ABBV
ABBV
1,421 hedge funds and large institutions have $56.7B invested in AbbVie in 2014 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 493 increasing their positions, 655 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,421
Holders Change
-11
Holders Change %
-0.77%
% of All Funds
41.07%
Holding in Top 10
51
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-13.56%
% of All Funds
1.47%
New
72
Increased
493
Reduced
655
Closed
67
Calls
$323M
Puts
$156M
Net Calls
+$167M
Net Calls Change
-$33M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$180M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$120M |
| 3 |
D.E. Shaw & Co
New York
|
+$116M |
| 4 |
FAM
Fred Alger Management
New York
|
+$107M |
| 5 |
HCM
Highline Capital Management
New York
|
+$105M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$253M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$213M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$202M |
| 4 |
State Street
Boston,
Massachusetts
|
-$200M |
| 5 |
Lazard Asset Management
New York
|
-$153M |
